Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation.

[1]  T. Nomura,et al.  Multipolarity of cytokine axes in the pathogenesis of atopic dermatitis in terms of age, race, species, disease stage and biomarkers , 2018, International immunology.

[2]  Uncommon Filaggrin Variants Are Associated with Persistent Atopic Dermatitis in African Americans. , 2018, The Journal of investigative dermatology.

[3]  Ning Zhang,et al.  Early‐onset pediatric atopic dermatitis is characterized by TH2/TH17/TH22‐centered inflammation and lipid alterations , 2018, The Journal of allergy and clinical immunology.

[4]  H. Uchi,et al.  The role of the OVOL1-OVOL2 axis in normal and diseased human skin. , 2018, Journal of dermatological science.

[5]  A. Alexis,et al.  Atopic dermatitis in diverse racial and ethnic groups—Variations in epidemiology, genetics, clinical presentation and treatment , 2018, Experimental dermatology.

[6]  A. Paller,et al.  Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin. , 2016, The Journal of allergy and clinical immunology.

[7]  R. Chakraborty,et al.  Resolving the etiology of atopic disorders by using genetic analysis of racial ancestry. , 2016, The Journal of allergy and clinical immunology.

[8]  V. Aoki,et al.  Skin barrier in atopic dermatitis: beyond filaggrin* , 2016, Anais brasileiros de dermatologia.

[9]  Manuel A. R. Ferreira,et al.  Th2/Th17 reciprocal regulation: twists and turns in the complexity of asthma phenotypes. , 2016, Annals of translational medicine.

[10]  M. Lebwohl,et al.  Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism. , 2016, The Journal of allergy and clinical immunology.

[11]  T. Honda,et al.  The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. , 2015, The Journal of allergy and clinical immunology.

[12]  Jing Chen,et al.  NDEx, the Network Data Exchange. , 2015, Cell systems.

[13]  C. Workman,et al.  Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways , 2015, BMC Medical Genomics.

[14]  Manuel A. R. Ferreira,et al.  Multi-ethnic genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis , 2015, Nature Genetics.

[15]  H. Hennies,et al.  Diverse regulation of claudin-1 and claudin-4 in atopic dermatitis. , 2015, The American journal of pathology.

[16]  J. Egen,et al.  TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma , 2015, Science Translational Medicine.

[17]  Mayte Suárez-Fariñas,et al.  RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications. , 2015, The Journal of allergy and clinical immunology.

[18]  R. Robinson.  IL12Rβ1: the cytokine receptor that we used to know. , 2015, Cytokine.

[19]  P. Fulkerson,et al.  Hospital admission associates with higher total IgE level in pediatric patients with asthma. , 2015, The journal of allergy and clinical immunology. In practice.

[20]  T. Litman,et al.  Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection. , 2015, The Journal of allergy and clinical immunology.

[21]  G. Yancopoulos,et al.  Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis. , 2014, The Journal of allergy and clinical immunology.

[22]  Jane A Hoppin,et al.  Prevalence of allergic sensitization in the United States: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2006. , 2014, The Journal of allergy and clinical immunology.

[23]  M. Suárez-Fariñas,et al.  Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. , 2014, The Journal of allergy and clinical immunology.

[24]  J. Bouwstra,et al.  TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents. , 2014, The Journal of investigative dermatology.

[25]  M. Suárez-Fariñas,et al.  Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology. , 2014, The Journal of allergy and clinical immunology.

[26]  D. Margolis,et al.  Exome sequencing of Filaggrin and related genes in African-American children with atopic dermatitis , 2014, The Journal of investigative dermatology.

[27]  D. Margolis,et al.  Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects. , 2014, The Journal of allergy and clinical immunology.

[28]  D. Margolis,et al.  Thymic stromal lymphopoietin variation, filaggrin loss of function, and the persistence of atopic dermatitis. , 2014, JAMA dermatology.

[29]  S. Kežić,et al.  South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin , 2014, The Journal of allergy and clinical immunology.

[30]  Kristin L. Sainani,et al.  Eczema and Sensitization to Common Allergens in the United States: A Multiethnic, Population‐Based Study , 2014, Pediatric dermatology.

[31]  Charity W. Law,et al.  voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.

[32]  H. Fujita.  The role of IL-22 and Th22 cells in human skin diseases. , 2013, Journal of dermatological science.

[33]  A. Leung,et al.  Barrier Repair Therapy in Atopic Dermatitis: An Overview , 2013, American Journal of Clinical Dermatology.

[34]  Ingo Ruczinski,et al.  African Ancestry is a Risk Factor for Asthma and High Total IgE Levels in African Admixed Populations , 2013, Genetic epidemiology.

[35]  Christopher R. Gignoux,et al.  A meta-analysis of genome-wide association studies for serum total IgE in diverse study populations. , 2013, The Journal of allergy and clinical immunology.

[36]  M. Simon,et al.  Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. , 2013, The Journal of allergy and clinical immunology.

[37]  Y. Tada,et al.  IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions. , 2013, The Journal of investigative dermatology.

[38]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[39]  M. Suárez-Fariñas,et al.  Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. , 2012, The Journal of allergy and clinical immunology.

[40]  H. Tey,et al.  Atopic Dermatitis in African American Children: Addressing Unmet Needs of a Common Disease , 2012, Pediatric dermatology.

[41]  M. Nordenskjöld,et al.  Novel filaggrin mutation but no other loss‐of‐function variants found in Ethiopian patients with atopic dermatitis , 2011, The British journal of dermatology.

[42]  J. Carucci,et al.  Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets. , 2011, The Journal of allergy and clinical immunology.

[43]  A. Bowcock,et al.  Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response. , 2011, The Journal of allergy and clinical immunology.

[44]  A. Ishida-Yamamoto,et al.  Order and disorder in corneocyte adhesion , 2011, The Journal of dermatology.

[45]  A. Bowcock,et al.  Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. , 2011, The Journal of allergy and clinical immunology.

[46]  A. Nikkels,et al.  Transcriptional profiling after lipid raft disruption in keratinocytes identifies critical mediators of atopic dermatitis pathways. , 2011, The Journal of investigative dermatology.

[47]  T. Agner,et al.  Ethnicity and stratum corneum ceramides , 2010, The British journal of dermatology.

[48]  T. Beaty,et al.  Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. , 2010, The Journal of allergy and clinical immunology.

[49]  Mayte Suárez-Fariñas,et al.  Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. , 2009, The Journal of allergy and clinical immunology.

[50]  R. Fölster-Holst,et al.  Role of the epidermal barrier in atopic dermatitis , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[51]  T. Beaty,et al.  Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. , 2009, The Journal of allergy and clinical immunology.

[52]  L. Liang,et al.  Genome-Wide Scan on Total Serum IgE Levels Identifies FCER1A as Novel Susceptibility Locus , 2008, PLoS genetics.

[53]  D. Vercelli,et al.  Discovering susceptibility genes for asthma and allergy , 2008, Nature Reviews Immunology.

[54]  G. Kaiko,et al.  Immunological decision‐making: how does the immune system decide to mount a helper T‐cell response? , 2008, Immunology.

[55]  Jon M Hanifin,et al.  A Population‐Based Survey of Eczema Prevalence in the United States , 2007, Dermatitis : contact, atopic, occupational, drug.

[56]  H. Zar,et al.  Prevalence of symptoms of asthma, rhinitis and eczema in 13‐ to 14‐year‐old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III , 2007, Allergy.

[57]  H. Wulf,et al.  Pigmentation after single and multiple UV-exposures depending on UV-spectrum , 2007, Archives of Dermatological Research.

[58]  D. Foell,et al.  Elevated serum levels of calcium‐binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis , 2006, The British journal of dermatology.

[59]  R. Schwartz,et al.  Adverse effects of topical glucocorticosteroids. , 2006, Journal of the American Academy of Dermatology.

[60]  T. Yoshimoto,et al.  A Role for IL-27 in Early Regulation of Th1 Differentiation1 , 2005, The Journal of Immunology.

[61]  A. Gurney,et al.  IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes1 , 2005, The Journal of Immunology.

[62]  C. Enerbäck,et al.  Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin‐B) in keratinocyte differentiation , 2005, Experimental dermatology.

[63]  B. Meibohm,et al.  Pharmacokinetics of immunosuppressants: a perspective on ethnic differences. , 2004, International journal of clinical pharmacology and therapeutics.

[64]  M. Capecchi,et al.  Role for ELOVL3 and Fatty Acid Chain Length in Development of Hair and Skin Function* , 2004, Journal of Biological Chemistry.

[65]  J. Drazen,et al.  Sequence variants in the FcεRI alpha chain gene , 2002 .

[66]  S. Feldman,et al.  In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis. , 2002, Archives of dermatology.

[67]  J. Dewar,et al.  Polymorphisms of the Beta Chain of the High-Affinity Immunoglobulin E Receptor (Fc ɛ RI- β ) in South African Black and White Asthmatic and Nonasthmatic Individuals , 1998 .

[68]  W. Ouyang,et al.  Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. , 1998, Immunity.

[69]  C. Bruijnzeel-Koomen,et al.  Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. , 1996, The Journal of allergy and clinical immunology.

[70]  P. Potter,et al.  The influence of ethnicity, an atopic family history, and maternal ascariasis on cord blood serum IgE concentrations. , 1988, The Journal of allergy and clinical immunology.

[71]  Grundbacher Fj,et al.  Levels of immunoglobulin G, M, A, and E at various ages in allergic and nonallergic black and white individuals , 1985 .

[72]  F. J. Grundbacher.  Causes of variation in serum IgE levels in normal populations. , 1975, The Journal of allergy and clinical immunology.